Kanova

About:

Kanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases.

Website: http://en.kanovabiopharma.com

Top Investors: Northern Light Venture Capital, BioVenture, CD Capital, Sino-Singapore Capital, ShenZhen GTJA Investment Group

Description:

Kanova is a biopharmaceutical company that focuses on developing therapeutic antibodies and innovative combination therapies in immuno-oncology and autoimmune diseases.

Total Funding Amount:

215M CNY

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2015-11-01

Contact Email:

hr(AT)kanovabiopharma.com

Founders:

Chen Dong

Number of Employees:

1-10

Last Funding Date:

2023-07-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai